Sol-Gel Technologies Ltd. (SLGL): Price and Financial Metrics
SLGL Price/Volume Stats
Current price | $0.44 | 52-week high | $1.58 |
Prev. close | $0.43 | 52-week low | $0.33 |
Day low | $0.44 | Volume | 51,900 |
Day high | $0.47 | Avg. volume | 139,633 |
50-day MA | $0.62 | Dividend yield | N/A |
200-day MA | $0.78 | Market Cap | 12.29M |
SLGL Stock Price Chart Interactive Chart >
Sol-Gel Technologies Ltd. (SLGL) Company Bio
Sol-Gel Technologies Ltd., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company’s lead product candidates include VERED that has completed Phase II clinical trials for the treatment of papulopustular rosacea; and TWIN and SIRS-T, which has completed Phase II clinical trials for the treatment of acne vulgaris. It is also involved in the development of generic dermatological candidates; and formulation and pre-clinical development of early stage product candidates for acne and rosacea, and other dermatological indications. The company was founded in 1997 and is based in Ness Ziona, Israel
SLGL Price Returns
1-mo | -34.33% |
3-mo | -31.89% |
6-mo | -45.00% |
1-year | -68.43% |
3-year | -94.43% |
5-year | -94.44% |
YTD | -60.18% |
2023 | -75.77% |
2022 | -38.38% |
2021 | -24.41% |
2020 | -42.92% |
2019 | 184.88% |
Continue Researching SLGL
Want to see what other sources are saying about Sol-Gel Technologies Ltd's financials and stock price? Try the links below:Sol-Gel Technologies Ltd (SLGL) Stock Price | Nasdaq
Sol-Gel Technologies Ltd (SLGL) Stock Quote, History and News - Yahoo Finance
Sol-Gel Technologies Ltd (SLGL) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...